Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Australia home healthcare market was valued at USD 10.41 Billion in 2025 and is expected to grow at a CAGR of 8.20%, reaching USD 22.89 Billion by 2035. The market growth is driven by population ageing, rising prevalence of chronic diseases, government support for home-based aged care, increasing adoption of hospital-at-home models, workforce pressures on hospitals, and growing use of remote monitoring and connected medical devices that enable patients to receive care outside traditional healthcare facilities.
Compound Annual Growth Rate
8.2%
Value in USD Billion
2026-2035
Read more about this report - Request a Free Sample
The Australia Home Healthcare Market encompasses a comprehensive range of medical equipment, diagnostic and monitoring devices, mobility assistance products, skilled nursing, rehabilitation, hospice and palliative care, respiratory therapy, infusion therapy, pregnancy care, and specialized services supporting healthcare delivery within residential settings. Home healthcare enables chronic disease management, post-acute care, rehabilitation, remote monitoring, supportive care, and individualized patient management across ageing populations and diverse medical conditions. The market was valued at USD 10.41 Billion in 2025, supported by increasing adoption of home-based care, growing demand for chronic disease management, expansion of hospital-at-home services, government investment in community-based healthcare, rising use of remote monitoring and connected medical devices, and technological advances in home-based diagnostics, respiratory care, mobility assistance, and digitally enabled healthcare delivery.
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Government Reform Is Strengthening the Structural Demand for Home-Based Care in Australia. |
Australia’s home healthcare market is being reshaped by the transition to the Support at Home program, which replaced Home Care Packages in November 2025. |
|
Market Restraints |
Workforce availability remains a material constraint as Australian home healthcare expands. |
The Australian Government also launched its 2026 Aged Care Provider Workforce Survey covering Support at Home and CHSP providers. |
|
Market Opportunities |
Australia is increasingly extending hospital-level treatment beyond conventional facilities through Hospital-in-the-Home and virtual-care models. |
In December 2025, Southern NSW Local Health District introduced digitally enabled HITH using Philips Australia and Respiree technology for continuous vital-sign monitoring. |
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Government Reform Is Strengthening the Structural Demand for Home-Based Care in Australia
Australia’s home healthcare market is being reshaped by the transition to the Support at Home program, which replaced Home Care Packages in November 2025. According to the Australian Government, the program is designed to keep older Australians living independently through coordinated clinical, personal-care and everyday-living services. Its 2026 expansion, including fully funded personal care from October, improves affordability and provider visibility. This policy-led shift should redirect healthcare expenditure toward community settings while creating more predictable demand for home nursing, personal care and allied-health services.
Workforce Capacity and Uneven Service Provision Remain Major Constraints on Home Healthcare Expansion
Workforce availability remains a material constraint as Australian home healthcare expands. A 2026 national description of Hospital-in-the-Home services found substantial variation in workforce composition, governance and technological capability across services. The Australian Government also launched its 2026 Aged Care Provider Workforce Survey covering Support at Home and CHSP providers. Persistent labor constraints can increase service-delivery costs, limit geographic expansion and reduce the scalability of labor-intensive home nursing and allied-health models.
Hospital-in-the-Home and Virtual Care Are Creating a Scalable Opportunity for Clinical Services at Home
Australia is increasingly extending hospital-level treatment beyond conventional facilities through Hospital-in-the-Home and virtual-care models. According to Linh Khanh Vo et al., 2025, a Queensland virtual HITH service demonstrated scalable implementation while relieving pressure on inpatient capacity. In December 2025, Southern NSW Local Health District introduced digitally enabled HITH using Philips Australia and Respiree technology for continuous vital-sign monitoring. These developments support capital-efficient care substitution, creating opportunities for remote monitoring, telehealth, home diagnostics and technology-enabled nursing services.
Digitally Enabled Hospital-at-Home Care Propelling the Market Landscape
The most important trend is the convergence of home healthcare with remote monitoring, virtual wards and digitally coordinated clinical pathways. In March 2026, Gold Coast Health selected Alcidion’s Miya Precision platform to integrate remote monitoring with its hospital network and community services, initially targeting post-acute and chronic-care patients. This reflects a broader shift from episodic home visits toward continuously connected care. Economically, such models can increase workforce productivity by concentrating clinical oversight around patients requiring active monitoring.
Read more about this report - Request a Free Sample
Diabetes Expected to Lead the Market Share by Indication
Diabetes is a leading indication for market, reflecting the substantial need for continuous glucose monitoring, insulin administration, medication management, and ongoing disease monitoring outside clinical settings. According to the AIHW, around 1.3 million Australians were living with diabetes in 2022-24, while diabetes accounted for 11% of hospitalizations in 2023-24. The prevalence of home-based diabetes management, supported by glucose monitoring and insulin delivery technologies, reinforces diabetes as a major demand center for home healthcare.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
ResMed develops connected medical devices, software and digital health solutions for sleep apnea, respiratory disorders and home-based care. Its portfolio includes CPAP and bilevel systems, masks, ventilators and remote-monitoring platforms. The company has a broad international presence and supports healthcare providers and patients through connected-care technologies that facilitate treatment outside traditional clinical settings.
Philips is a global health-technology company providing connected monitoring, diagnostic imaging, respiratory care and patient-management technologies. Its home healthcare portfolio includes sleep and respiratory solutions, remote patient monitoring and connected-care platforms. Philips serves hospitals and patients across international markets, with technologies increasingly supporting decentralized care, chronic-disease management and hospital-at-home models.
Medtronic develops medical devices and therapies spanning cardiovascular, diabetes, neuroscience and surgical care. Its technologies relevant to home healthcare include connected monitoring, diabetes-management systems and devices supporting chronic disease management. The company operates globally and increasingly incorporates digital connectivity and remote-management capabilities to extend clinical oversight beyond hospitals and specialist facilities.
Abbott is a diversified healthcare company operating across medical devices, diagnostics, nutrition and pharmaceuticals. Its portfolio includes continuous glucose monitoring, cardiovascular devices, diagnostic systems and technologies supporting chronic-disease management. Abbott’s connected monitoring technologies facilitate ongoing patient management outside traditional healthcare facilities, while its global commercial infrastructure supports adoption across clinical and home-based care environments.
Other key players in the market include OMRON Healthcare Co., Ltd., Fresenius Medical Care AG, Sunrise Medical Holdings Limited, Cochlear Limited, Silverchain Group Limited.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Offerings
Australia’s home healthcare offerings encompass medical equipment and professionally delivered services supporting diagnosis, treatment, rehabilitation, monitoring, and daily care. Equipment includes therapeutic, diagnostic, monitoring, and mobility products, while services provide skilled clinical and supportive care. Together, these offerings enable patients to receive increasingly complex healthcare interventions within residential and community settings.
Market Breakup by Indication
Australia’s home healthcare market serves diverse indications requiring continuous monitoring, treatment, rehabilitation, or supportive care outside conventional healthcare facilities. Chronic diseases such as diabetes, cardiovascular and respiratory conditions represent important demand areas, alongside cancer, mobility disorders, wound care, pregnancy, and hearing disorders. Ageing and increasing community-based care further broaden the range of conditions managed at home.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Offerings |
|
| Breakup by Indication |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.